Close Menu

NEW YORK – Hologic reported on Sunday revenue growth of greater than 2 percent for its fiscal first quarter 2020.

For the three months ended Dec. 28, 2019, the Marlborough, Massachusetts-based company recorded revenues of $850.5 million compared to $830.7 million in fiscal Q1 2019, and above the consensus Wall Street estimate of $839.2 million.

Hologic had guided to a range of $836 million to $850 million for fiscal Q1 2020.

On a constant currency basis, revenues for the recently completed quarter were up nearly 3 percent, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.